YHB Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,419
Closed -$208K 297
2024
Q4
$208K Sell
2,419
-865
-26% -$93.5K 0.02% 274
2024
Q3
$391K Buy
3,284
+334
+11% +$44.5K 0.03% 218
2024
Q2
$421K Buy
2,950
+250
+9% +$33.1K 0.04% 213
2024
Q1
$347K Buy
+2,700
New +$321K 0.03% 221

Other funds holding NVO

YHB Investment Advisors's NVO Position: Q1 2025 in Review

YHB Investment Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,419 shares — an estimated $208K sold.

YHB Investment Advisors first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $421K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • YHB Investment Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • YHB Investment Advisors sold 2,419 Novo Nordisk shares in Q1 2025, an estimated $208K.
  • YHB Investment Advisors first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • YHB Investment Advisors's Novo Nordisk position peaked at $421K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on YHB Investment Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.